Sanuwave completes 1-for-375 reverse split, $10.3M PIPE, and note exchange

SANUWAVE Health, Inc.

Reverse stock split 1-for-375 effective Oct 18; outstanding shares post-restructuring ~8.5M.
Exchanged $43.2M in convertible notes and associated warrants for ~4.0M post-split shares.
Closed $10.3M PIPE at $8.25/share led by AWM Investment, Manchester Management, Opaleye.
Entered consent/limited waiver with NH Expansion; repaid HealthTronics $1.4M note, regaining debt covenant compliance.
CEO Morgan Frank states transactions simplify cap table and position company for growth and profitability.

item 1.01 item 3.02 item 3.03 item 5.03 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

SANUWAVE Health, Inc.: Filing of Certificate of Amendment to Articles of Incorporation to implement a 1-for-375 reverse stock split of Common Stock (effective 2024-10-18).

Change: charter amendment
Effective: 2024-10-18

Exact text from the filing

On October 15, 2024, the Company filed a Certificate of Amendment to its Articles of Incorporation, as amended (the "Certificate of Amendment"), to implement a 1-for-375 reverse stock split (the "Reverse Stock Split") of Common Stock.

View on SEC.gov

Browse all governance changes →

SANUWAVE Health, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-24-043082

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.